ÌÇÐÄvlog

[Skip to Navigation]
Sign In

November 2024, Vol 184, No. 11, Pages 1276-1396

Viewpoint

Women's Health

The White House Initiative on Women’s Health Research

Abstract Full Text
JAMA Intern Med. 2024;184(11):1277-1278. doi:10.1001/jamainternmed.2024.3592

This Viewpoint explores the 2023 White House Initiative on Women’s Health Research, which seeks to change how women’s health research is approached and funded to improve the lives of women and the health of the nation.

Women's Health

Contraceptive Access in the US Post-Dobbs

Abstract Full Text
JAMA Intern Med. 2024;184(11):1279-1280. doi:10.1001/jamainternmed.2024.3586

This Viewpoint contraceptive justice after the Dobbs v Jackson Women’s Health Organization US Supreme Court decision, which led to a decline in contraceptive access, especially in states with abortion bans.

Women's Health

Screening Mammography for 40-Year-Old Women—Whose Decision?

Abstract Full Text
JAMA Intern Med. 2024;184(11):1281-1282. doi:10.1001/jamainternmed.2024.4277

This Viewpoint discusses the potential risks and benefits for starting screening at 40 rather than 50 years of age and whether clinicians or patients should decide based on risk rather than age.

Cybersecurity Lessons From the Change Healthcare Attack

Abstract Full Text
JAMA Intern Med. 2024;184(11):1283-1284. doi:10.1001/jamainternmed.2024.3162

This Viewpoint describes the consequences of the ransomware attack on Change Healthcare and the need for increased cybersecurity measures in the health care infrastructure.

How to Choose the Best Job for You

Abstract Full Text
JAMA Intern Med. 2024;184(11):1285-1286. doi:10.1001/jamainternmed.2024.3589

This Viewpoint provides practicing clinicians who are considering choosing a new employer with guidance about questions relevant to evaluating governance, rewards systems, and culture.

Inside Story

Health Equity

Language Discordance and Patient Care—Babel

Abstract Full Text
JAMA Intern Med. 2024;184(11):1287-1288. doi:10.1001/jamainternmed.2024.4273

This essay discusses the importance of available, affordable, and adequate interpreter services to eliminate patient-clinician language discordance.

Original Investigation

Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology: Post Hoc Analysis of the STEP 1, 2, 3, and 5 Trials

Abstract Full Text
open access
JAMA Intern Med. 2024;184(11):1290-1300. doi:10.1001/jamainternmed.2024.4346

This post hoc analysis of 4 randomized clinical trials evaluates the psychiatric safety of subcutaneous semaglutide, 2.4 mg, once weekly in people with obesity or overweight without known major psychopathology.

GLP-1 Receptor Agonist Use and Risk of Suicide Death

Abstract Full Text
open access
JAMA Intern Med. 2024;184(11):1301-1312. doi:10.1001/jamainternmed.2024.4369

This cohort study assesses the association between use of glucagon-like peptide-1 receptor agonists and the risk of suicide death in routine clinical practice.

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Abstract Full Text
has audio
JAMA Intern Med. 2024;184(11):1314-1323. doi:10.1001/jamainternmed.2024.4661

This cohort study aims to determine whether use of glucagon-like peptide 1 receptor agonists are associated with lower risk of developing cirrhosis and its complications, including decompensation and hepatocellular cancer, among patients with metabolic dysfunction-associated steatotic liver disease.

Health Equity

Individual-Level Exposure to Residential Redlining in 1940 and Mortality Risk

Abstract Full Text
JAMA Intern Med. 2024;184(11):1324-1328. doi:10.1001/jamainternmed.2024.4998

This study explores whether individuals who resided in US Home Owners’ Loan Corporation redlined neighborhoods in 1940 had lower life expectancy later in life compared with individuals who resided in neighborhoods that were not redlined.

Health Equity

Redlining and Time to Viral Suppression Among Persons With HIV

Abstract Full Text
JAMA Intern Med. 2024;184(11):1329-1337. doi:10.1001/jamainternmed.2024.5003

This study assesses the effect of redlining on time to viral suppression among people newly diagnosed with HIV in New Orleans, Louisiana.

Less Is More

Patient-Directed Education to Promote Deprescribing: A Nonrandomized Clinical Trial

Abstract Full Text
JAMA Intern Med. 2024;184(11):1339-1346. doi:10.1001/jamainternmed.2024.4739

This pragmatic nonrandomized multisite clinical trial examines the effectiveness of patient-directed educational materials provided before primary care appointments in promoting deprescribing for low-benefit and high-risk medication groups.

Less Is More

Deprescribing of Antihypertensive Medications and Cognitive Function in Nursing Home Residents

Abstract Full Text
JAMA Intern Med. 2024;184(11):1347-1355. doi:10.1001/jamainternmed.2024.4851

This cohort study investigates the association between antihypertensive deprescribing and changes in cognitive function in nursing home residents.

Nurse-Supported Self-Directed Cognitive Behavioral Therapy for Insomnia: A Randomized Clinical Trial

Abstract Full Text
JAMA Intern Med. 2024;184(11):1356-1364. doi:10.1001/jamainternmed.2024.4419

This randomized clinical trial examines the effectiveness of a nurse-supported, self-directed behavioral insomnia intervention for decreasing insomnia severity and improving sleep outcomes among veterans.

Lactated Ringer vs Normal Saline Solution During Sickle Cell Vaso-Occlusive Episodes

Abstract Full Text
JAMA Intern Med. 2024;184(11):1365-1372. doi:10.1001/jamainternmed.2024.4428

This multicenter retrospective cohort study examines the comparative effectiveness of lactated Ringer solution vs normal saline for fluid resuscitation in inpatients with sickle cell disease and vaso-occlusive episodes.

Reaction Risk to Direct Penicillin Challenges: A Systematic Review and Meta-Analysis

Abstract Full Text
JAMA Intern Med. 2024;184(11):1374-1383. doi:10.1001/jamainternmed.2024.4606

This systematic review and meta-analysis evaluates the frequency of reactions to direct penicillin challenges in individuals with penicillin allergy labels across diverse patient populations.

Editorial

Less Is More

Educational Brochures for Deprescribing

Abstract Full Text
JAMA Intern Med. 2024;184(11):1289. doi:10.1001/jamainternmed.2024.4755
Invited Commentary

Health Equity

Racial Residential Segregation, Redlining, and Health

Abstract Full Text
JAMA Intern Med. 2024;184(11):1337-1338. doi:10.1001/jamainternmed.2024.5011

Charting the Waters of Sickle Cell Disease With Target Trial Emulation

Abstract Full Text
JAMA Intern Med. 2024;184(11):1372-1373. doi:10.1001/jamainternmed.2024.4435
Editor's Note

Glucagon-Like Peptide-1 Receptor Agonists and Suicidality—Two Important Pieces of Data but an Incomplete Puzzle

Abstract Full Text
JAMA Intern Med. 2024;184(11):1312-1313. doi:10.1001/jamainternmed.2024.4320
Teachable Moment

Diagnostic Inertia in Identifying Maturity-Onset Diabetes of the Young

Abstract Full Text
has active quiz
JAMA Intern Med. 2024;184(11):1384-1385. doi:10.1001/jamainternmed.2024.2931

This case report describes a woman in her mid 30s with diabetes who had been treated with insulin therapy, no history of diabetic ketoacidosis, and normal levels of C-peptide.

Research Letter

Less Is More

Direct-to-Consumer Educational Brochures to Promote Gabapentinoid Deprescribing in Older Adults

Abstract Full Text
open access
JAMA Intern Med. 2024;184(11):1386-1388. doi:10.1001/jamainternmed.2024.4748

This study examines gabapentinoid deprescribing using a novel approach of direct-to-consumer educational brochures intended to empower older adults to initiate a discussion on gabapentinoid risks and tapering.

Mapping the Evidence Supporting Digital Therapeutics: A Review

Abstract Full Text
JAMA Intern Med. 2024;184(11):1388-1390. doi:10.1001/jamainternmed.2024.4972

This systematic review assesses the availability and temporality of evidence from effectiveness and efficacy studies for digital therapeutics.

Health Care Policy and Law

Estimated Savings Under the Medicare High-Value Drug List Model

Abstract Full Text
JAMA Intern Med. 2024;184(11):1390-1392. doi:10.1001/jamainternmed.2024.4846

This cross-sectional study describes potential reductions in out-of-pocket costs for generic medications among Medicare beneficiaries.

Comment & Response

Cytisinicline For E-Cigarette Cessation

Abstract Full Text
JAMA Intern Med. 2024;184(11):1392-1393. doi:10.1001/jamainternmed.2024.4409

Cytisinicline For E-Cigarette Cessation

Abstract Full Text
JAMA Intern Med. 2024;184(11):1393. doi:10.1001/jamainternmed.2024.4412

Cytisinicline For E-Cigarette Cessation—Reply

Abstract Full Text
JAMA Intern Med. 2024;184(11):1393-1394. doi:10.1001/jamainternmed.2024.4415

Tick Paralysis—A Rare but Important Tick-Borne Disease

Abstract Full Text
JAMA Intern Med. 2024;184(11):1394-1395. doi:10.1001/jamainternmed.2024.4797

Insights for Using Jinlida in Diabetes Prevention

Abstract Full Text
JAMA Intern Med. 2024;184(11):1395. doi:10.1001/jamainternmed.2024.4989

Insights for Using Jinlida in Diabetes Prevention

Abstract Full Text
JAMA Intern Med. 2024;184(11):1395-1396. doi:10.1001/jamainternmed.2024.4992

Insights for Using Jinlida in Diabetes Prevention—Reply

Abstract Full Text
JAMA Intern Med. 2024;184(11):1396. doi:10.1001/jamainternmed.2024.4995
Correction

Error in Figure 1

Abstract Full Text
free access
JAMA Intern Med. 2024;184(11):1396. doi:10.1001/jamainternmed.2024.6163
JAMA Internal Medicine Masthead

JAMA Internal Medicine

Abstract Full Text
free access
JAMA Intern Med. 2024;184(11):1276. doi:10.1001/jamainternmed.2023.5588
×